Evidence map›Paper›PMID 32390254›Full record

ArticleStatistics in medicine2020

Sample-weighted semiparametric estimation of cause-specific cumulative risk and incidence using left- or interval-censored data from electronic health records.

Noorie Hyun, Hormuzd A Katki, Barry I Graubard

Open access · greenAbstract read
In one paragraph

Article in Statistics in medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Noorie HyunDivision of Biostatistics, Medical College of Wisconsin, Wauwatosa, Wisconsin, USA.ORCID 0000-0002-8923-1184
Hormuzd A KatkiDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.ORCID 0000-0003-2002-0095
Barry I GraubardDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.
National Cancer Institute · USMedical College of Wisconsin · US

Funding

Consultation and CollaborationZIACP010184 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI GRAUBARD, BARRY · 2010 to 2020
$16.3M
Intramural NIH HHS ZIA CP010184
6 · The paper itself

Abstract

Electronic health records (EHRs) can be a cost-effective data source for forming cohorts and developing risk models in the context of disease screening. However, important issues need to be handled: competing outcomes, left-censoring of prevalent disease, interval-censoring of incident disease, and uncertainty of prevalent disease when accurate disease ascertainment is not conducted at baseline. Furthermore, novel tests that are costly and limited in availability can be conducted on stored biospecimens selected as samples from EHRs by using different sampling fractions. We extend sample-weighted semiparametric marginal mixture models to estimating competing risks. For flexible modeling of relative risks, a general transformation of the subdistribution hazard function and regression parameters is used. We propose a numerical algorithm for nonparametrically calculating the maximum likelihood estimates for subdistribution hazard functions and regression parameters. Methods for calculating the consistent confidence intervals for relative and absolute risk estimates are presented. The proposed algorithm and methods show reliable finite sample performance through simulation studies. We apply our methods to a cohort assembled from EHRs at a health maintenance organization where we estimate cumulative risk of cervical precancer/cancer and incidence of infection-clearance by HPV genotype among human papillomavirus (HPV) positive women. There is no significant difference in 3-year HPV-clearance rates across different HPV types, but 3-year cumulative risk of progression-to-precancer/cancer from HPV-16 is relatively higher than the other HPV genotypes.

Indexed as

Electronic Health RecordsUterine Cervical NeoplasmsFemaleHumansIncidenceLikelihood FunctionsPapillomaviridaecompeting risksleft/interval censoringnonparametric maximum likelihood estimationstratified random sample

Identifiers

PMID32390254
PMCPMC12416197
OpenAlexW3021037119

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.